Congress orders study of why Medicaid won't cover pregnancy monitors

What it does

This bill directs the federal government to study why state Medicaid programs don't consistently cover remote health-monitoring devices (like pulse oximeters and blood pressure cuffs) for pregnant and postpartum women, and to recommend fixes. Within 18 months, HHS must report on barriers to coverage; within 6 months after that, it must update guidance to states to align with those recommendations. The goal is to improve maternal and child health outcomes by expanding access to remote monitoring for low-income pregnant women on Medicaid.

Why we flagged it

The bill is a straightforward directive for federal study and state-guidance update aimed at removing barriers to maternal health coverage under Medicaid. It is not a funding mechanism, a regulatory change, or a carve-out—it is a fact-finding and coordination mandate in service of a public-health goal.

What the text implies

• The bill does not mandate coverage or appropriate funds; it only directs study and guidance. States retain discretion to ignore recommendations, so actual coverage expansion depends on state political will and budget capacity.
• Remote monitoring devices are manufactured by private companies; expanded Medicaid coverage would increase demand and revenue for device makers, though the bill itself does not name or directly benefit any company.
• The 18-month study timeline may delay coverage improvements for pregnant women currently on Medicaid, as the bill creates no immediate coverage mandate.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Pregnant and postpartum women on Medicaid—a vulnerable, low-income population at high risk for maternal mortality and morbidity—stand to gain access to remote monitoring devices that can detect complications early. The bill imposes no restrictions on citizens' rights or remedies; it mandates study and guidance to remove barriers to coverage, which is a public-health measure aimed at reducing maternal harm.

Who stands to gain

• remote physiologic device manufacturers (pulse oximeters, blood pressure monitors, scales, glucose m
• telehealth platform providers

Named in the bill

HHS (Department of Health and Human Services), State Medicaid programs, pregnant and postpartum women, remote physiologic monitoring device manufacturers

Where it stands

12 cosponsors: 7 Democrats, 5 Republicans.

• Aug 15, 2025 — Introduced · Congress.gov: “Introduced in House”
• Aug 15, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $5,703,000 in lobbying spend. A filing names 103 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Lois Frankel, the sponsor, reported $555,750 in PAC receipts in the 2026 cycle.

• American Medical Association — $5,643,000 on 2 filings
• Hadassah, the Women's Zionist Organization of America, Inc. — $60,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.